Piperonyl butoxide, Pyrethrum · PIPERONYL BUTOXIDE 35 mg/mL; PYRETHRUM EXTRACT 3 mg/mL · Gel · Topical · GM Pharmaceuticals, INC
NDC 58809-0650-08 · 237 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| GM Pharmaceuticals, INC | PIPERONYL BUTOXIDE 35 mg/mL; PYRETHRUM EXTRACT 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Vanalice — NDC 58809-0650-08," retrieved September 3, 2026, https://drugdashboards.com/drug/58809065008.
Free to cite with attribution — see how the data is put together.